CRISPR Therapeutics to present at Needham Virtual Healthcare Conference on April 13, 2026.

CRISPR Therapeutics announced that its senior management will present at the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026. The presentation will be webcast live and available for replay on the company's website. CRISPR Therapeutics is a leading biopharmaceutical company known for developing gene-based medicines, including the first approved CRISPR therapy for sickle cell disease and beta thalassemia. The company continues to advance its gene-editing platform and pipeline, collaborating with partners like Vertex Pharmaceuticals to expand its impact in treating serious diseases.